View in EDS HTML Full Text PDF Full Text

The de novo DNA methyltransferase 3B is a novel epigenetic regulator of MYC in multiple myeloma, representing a promising therapeutic target to counter relapse.

Saved in:
Bibliographic Details
Title: The de novo DNA methyltransferase 3B is a novel epigenetic regulator of MYC in multiple myeloma, representing a promising therapeutic target to counter relapse.
Authors: Muylaert, Catharina1 (AUTHOR), Van Hemelrijck, Lien Ann1 (AUTHOR), Van der Vreken, Arne1 (AUTHOR), Heestermans, Robbe2,3 (AUTHOR), Satilmis, Hatice1 (AUTHOR), Verheye, Emma1 (AUTHOR), Alaterre, Elina4 (AUTHOR), Olsen, Catharina5,6,7 (AUTHOR), De Beule, Nathan1,2 (AUTHOR), De Veirman, Kim1,2 (AUTHOR), Menu, Eline1 (AUTHOR), Vanderkerken, Karin1 (AUTHOR), Moreaux, Jérôme8,9,10 (AUTHOR), De Bruyne, Elke1 (AUTHOR) Elke.De.Bruyne@vub.be
Source: Journal of Experimental & Clinical Cancer Research (17569966). 4/17/2025, Vol. 44 Issue 1, p1-18. 18p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17569966
DOI:10.1186/s13046-025-03382-y